Rigel Pharmaceuticals, Inc. has announced the approval of a new Inducement Plan by its Board's Compensation Committee, aimed at providing stock-based incentives to employees. As part of this plan, Rigel has granted 23,075 stock options and restricted stock units to 10 non-executive employees. These awards are set to vest over a four-year period, with an initial one-year cliff, in compliance with NASDAQ Listing Rule 5635(c)(4). This move is part of Rigel's efforts to recognize and reward its employees as they join the company.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.